List view / Grid view
11 July 2016 | By Victoria White, Digital Content Producer
If approved, RVT-101 could be the first Alzheimer’s treatment in 14 years. The last drug to be approved to help improve cognition was Donepezil in 2002...
11 July 2016 | By Victoria White, Digital Content Producer
Viridian Pharma has developed five products that have regulatory approval in the UK and represent first-to-market specialty hospital-prescribed medicines...
8 July 2016 | By Victoria White, Digital Content Producer
The S-TRAC study of Sutent versus placebo in the adjuvant setting met its primary endpoint of improving disease-free survival in renal cell carcinoma...
8 July 2016 | By Victoria White, Digital Content Producer
Eisai has expressed concern that patients in England and Wales will have to wait three years to access Lenvatinib due to a ‘black hole’ in the CDF process...
8 July 2016 | By CPhI
CPhI Korea is experiencing a huge surge in interest; with over 5000 pharma professionals envisaged to converge at the COEX centre during the three-day event...
7 July 2016 | By Victoria White, Digital Content Producer
This important decision allows reimbursed access to Translarna, the first approved therapy to treat the underlying cause of Duchenne muscular dystrophy...
7 July 2016 | By Victoria White, Digital Content Producer
Nearly half of adult patients treated with Humira achieved at least a 75% improvement in their fingernail psoriasis compared to patients receiving placebo...
7 July 2016 | By Victoria White, Digital Content Producer
The EC has granted an extension of the Market Authorisation for Revestive for the treatment of patients aged one year and above with Short Bowel Syndrome...
7 July 2016 | By Victoria White, Digital Content Producer
The EGALITY study involved 531 patients and compared the efficacy and safety of biosimilar etanercept with the originator product, Enbrel...
7 July 2016 | By Victoria White, Digital Content Producer
Bosutinib is the first drug to go through the reappraisal process, where NICE assesses the cost and clinical effectiveness of drugs currently in the old CDF...
7 July 2016 | By Victoria White, Digital Content Producer
In the recent Referendum, the majority voted against the UK's continued membership of the EU. Now, the EMA has issued a statement on the outcome of the vote...
6 July 2016 | By Victoria White, Digital Content Producer
The type 2 diabetes market will see companies prioritisng competitive pricing in order to offset the impact of patent expiries, says GlobalData...
6 July 2016 | By Victoria White, Digital Content Producer
Scientists have developed a cost-effective vaccine cooler which preserves vaccines for 35 days using just 30 litres of ice and without needing electricity...
6 July 2016 | By Victoria White, Digital Content Producer
Avelumab will be evaluated in combination with, and/or as follow-on treatment to, platinum-based chemotherapy in patients with epithelial ovarian cancer...
6 July 2016 | By Victoria White, Digital Content Producer
The EC has extended the current conditional marketing authorisation of Adcetris as consodlidation treatment in post-transplant Hodgkin lymphoma...
